Where does Sage Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sage Therapeutics, Inc. ranks #3,981 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sage Therapeutics, Inc. hold?

Sage Therapeutics, Inc. holds 91 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is Sage Therapeutics, Inc.'s Innovation Score?

Sage Therapeutics, Inc. has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sage Therapeutics, Inc. focus on?

Sage Therapeutics, Inc.'s top technology area is C07J (Steroids) with 85 patents, ranking #1 of 212 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Sage Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Sage Therapeutics, Inc.'s recent grant velocity is +215% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Sage Therapeutics, Inc.'s patents?

Sage Therapeutics, Inc.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sage Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sage Therapeutics, Inc.

USPTO PatentsView assignee record - 91 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07J (Steroids).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sage ranks #3,981 of 49,997 tracked US assignees by granted-patent volume, with 91 patents across 7 technology areas.

#3,981
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 16.4
avg claims per patent: +215%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3981 · US Corporation #3,981 · 91 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 91 grants
TOP-DECILE #3,981/49,997
PHOTO-FINISH Patent Investment &…
CPC-NARROW C07J · 7 areas
INNOV-PAR 42.8/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +215% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Patent Investment & Licensing Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sage’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.6 pts (36%) Velocity 8.0 pts (19%) Breadth 9.4 pts (22%) Claim depth 9.9 pts (23%)

Qualcomm Incorporated · highest

85
iBiquity Digital · near

43
Leap Motion · near

43
Sage Therapeutics · this assignee

43
Macneil IP · near

43
Narrative Science · near

43
3D Lighting… · lowest

7

What this shows Sage's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sage?

Each dot is one of Sage’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sage’s own 16.4 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sage vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sage's grants concentrate

Sage Therapeutics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 93.4% of grants classified under C07J (Steroids). Peak complete grant year is 2024 (22 grants) versus a trough of 1 in 2018. By volume, Sage sits between Patent Investment & Licensing Company and Tsmc Nanjing Company, Limited.

Sage's three-year grant acceleration

From 2019–2021 to 2022–2024, Sage Therapeutics, Inc. moved from 35 to 42 grants (1.20x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Patent Investment…

91
SOCIÉTÉ BIC

91
Suzhou Opple Ligh…

91
Synventive Moldin…

91
Saint Louis Unive…

91
Silgan White Cap

91
Tango Networks

91
Tsmc Nanjing

91
Sage Therapeutics ◀

91

What this shows Sage holds 91 patents at rank #3,984, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sage

By rank, the assignees closest to #3,984 in granted patent volume.

Leaders in C07J (Steroids)

Other assignees with the most granted patents in Sage's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sage, neither rank-band nor same-CPC leaders (those blocks stay above). In C07J (Steroids), Sage ranks #1 of 212 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Leap Motion, Inc. 43 Macneil IP LLC 43 iBiquity Digital Corporation 43 Narrative Science LLC 43

Similar claim depth

Nearest assignees by average claims per patent (16.4 here).

Bruker Biospin GmbH 16.4 avg Kids II, Inc. 16.4 avg Pharmacyclics LLC 16.4 avg Tesla Motors, Inc. 16.4 avg

Sage's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Sage Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	2.2%
2017	3	3.3%
2018	1	1.1%
2019	14	15.4%
2020	11	12.1%
2021	10	11.0%
2022	10	11.0%
2023	10	11.0%
2024	22	24.2%
2025partial year	8	8.8%

Which technologies does Sage Therapeutics, Inc. patent most?

C07J - Steroids 85

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 74

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 40

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 10

C07D - Heterocyclic Compounds 5

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sage Therapeutics, Inc.'s patent record in context - here's where to go next.

Sage Therapeutics, Inc.'s lead technology class is C07J (Steroids), 93.4% of its portfolio - see every assignee active in that class. Explore C07J
Ranked #3,981 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sage Therapeutics, Inc. against Patent Investment & Licensing Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.